Anchor Investment Management’s NovoCure NVCR Stock Holding History

Anchor Investment Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$273	Hold	25	–	–	﹤0.01%	1049
2025 Q4	$323	Hold	25	–	–	﹤0.01%	1027
2025 Q3	$323	Hold	25	–	–	﹤0.01%	1042
2025 Q2	$445	Hold	25	–	–	﹤0.01%	1017
2025 Q1	$446	Hold	25	–	–	﹤0.01%	1011
2024 Q4	$745	Hold	25	–	–	﹤0.01%	985
2024 Q3	$391	Hold	25	–	–	﹤0.01%	1024
2024 Q2	$428	Hold	25	–	–	﹤0.01%	974
2024 Q1	$391	Hold	25	–	–	﹤0.01%	1011
2023 Q4	$373	Hold	25	–	–	﹤0.01%	940
2023 Q3	$404	Hold	25	–	–	﹤0.01%	956
2023 Q2	$1.04K	Hold	25	–	–	﹤0.01%	920
2023 Q1	$1.5K	Hold	25	–	–	﹤0.01%	925
2022 Q4	$1.83K	Hold	25	–	–	﹤0.01%	878
2022 Q3	$1.9K	Hold	25	–	–	﹤0.01%	889
2022 Q2	$1.74K	Hold	25	–	–	﹤0.01%	901
2022 Q1	$2.07K	Hold	25	–	–	﹤0.01%	909
2021 Q4	$1.88K	Buy	+25	New	+$2.51K	﹤0.01%	941

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Anchor Investment Management's NVCR Position: Q1 2026 in Review

Anchor Investment Management held its NovoCure (NVCR) position steady in Q1 2026 at 25 shares worth $273. The position accounts for ﹤0.01% of the portfolio, ranked #1049.

Anchor Investment Management first reported a position in NVCR in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.07K in Q1 2022. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

Anchor Investment Management held 25 shares of NovoCure worth $273 as of Q1 2026.
Anchor Investment Management left its NovoCure share count unchanged in Q1 2026.
NovoCure made up ﹤0.01% of Anchor Investment Management's portfolio in Q1 2026, its #1049 holding.
Anchor Investment Management first reported a position in NovoCure in Q4 2021 and has held it in 18 quarters since.
Anchor Investment Management's NovoCure position peaked at $2.07K in Q1 2022.
222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.